<DOC>
	<DOCNO>NCT00597649</DOCNO>
	<brief_summary>This study evaluate long-term efficacy safety two dosage bicifadine SR ( 600 mg/day 1200 mg/day ) 52 week reduce chronic peripheral neuropathy pain due diabetes adult outpatient .</brief_summary>
	<brief_title>A 52-Week Study Bicifadine Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Male female 18 year old Diagnosis type 1 type 2 noninsulin dependent diabetes mellitus Chronic bilateral pain due diabetic neuropathy , pain least six month . Primary pain located foot . Subject participate complete XTL 07001 clinical trial . Contact site additional information . Symptoms painful condition Presence amputation toe Clinically significant psychiatric neuropsychological disorder Use certain medication Clinically important disease Pregnancy History alcohol narcotic abuse within two year . Contact site additional information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>